Terns Pharmaceuticals, Inc. ($TERN)
Filing Information
| Accession Number | 0001892413-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 16, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
168,750
Total Value
$0.00
P&L
+inf% (+$8,174,250.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 14, 2026 | Grant/Award | 56,250 | $0.00 | $0.00 | 106,615 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jan 14, 2026 | Grant/Award | 112,500 | $0.00 | $0.00 | 112,500 | Direct | โ | View Details |